Latest News

Latest News

SUNSHINE BIOPHARMA BELIEVES THAT AN EFFECTIVE CORONAVIRUS TREATMENT CONTINUES TO BE NECESSARY

SUNSHINE BIOPHARMA BELIEVES THAT AN EFFECTIVE CORONAVIRUS TREATMENT CONTINUES TO BE NECESSARY

adminNovember 24, 20205 min read

For Immediate Release November 24, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of  oncology and…

Sunshine Biopharma Signs an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound

Sunshine Biopharma Signs an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound

adminNovember 19, 20204 min read

Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of  oncology and antiviral drugs today announced that it…

Sunshine Biopharma Signs an Agreement for Distribution of Essential-9TM in Asia and the Far East

Sunshine Biopharma Signs an Agreement for Distribution of Essential-9TM in Asia and the Far East

adminNovember 10, 20204 min read

For Immediate Release November 10, 2020 Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Pink: “SBFM”) today announced that it has signed an agreement with JOAH International Pte.,…

SUNSHINE BIOPHARMA RECEIVES SECOND TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT

SUNSHINE BIOPHARMA RECEIVES SECOND TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT

adminOctober 26, 20204 min read

For Immediate Release October 26, 2020 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology…

CEO of Sunshine Biopharma, Dr. Steve Slilaty, is Featured on The Stock Day Podcast

CEO of Sunshine Biopharma, Dr. Steve Slilaty, is Featured on The Stock Day Podcast

adminOctober 22, 20206 min read

Phoenix, October 22nd, 2020 (Newsfile Corp.) — The Stock Day Podcast welcomed Sunshine Biopharma (SBFM) (“the Company”), a company working on the development of a treatment for COVID-19, as well…

SUNSHINE BIOPHARMA AND UNIVERSITY OF GEORGIA TEAM UP TO DEVELOP A NEW ANTI-CORONAVIRUS DRUG

SUNSHINE BIOPHARMA AND UNIVERSITY OF GEORGIA TEAM UP TO DEVELOP A NEW ANTI-CORONAVIRUS DRUG

adminOctober 19, 20205 min read

For Immediate Release October 19, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and…

SUNSHINE BIOPHARMA IDENTIFIES A LEAD ANTI-CORONAVIRUS COMPOUND

SUNSHINE BIOPHARMA IDENTIFIES A LEAD ANTI-CORONAVIRUS COMPOUND

adminOctober 7, 20205 min read

For Immediate Release – October 7, 2020. Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), apharmaceutical company focused on the research, development and commercialization ofoncology and antiviral…

SUNSHINE BIOPHARMA SECURES $2,000,000 FINANCING FOR CORONAVIRUS TREATMENT

SUNSHINE BIOPHARMA SECURES $2,000,000 FINANCING FOR CORONAVIRUS TREATMENT

adminSeptember 15, 20205 min read

For Immediate Release – September 15, 2020. Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC Markets:“SBFM”), a pharmaceutical company focused on the research, development andcommercialization of oncology and…

SUNSHINE BIOPHARMA COMPLETES THE SYNTHESIS OF FOUR POTENTIAL INHIBITORS OF CORONAVIRUS PROTEASE

SUNSHINE BIOPHARMA COMPLETES THE SYNTHESIS OF FOUR POTENTIAL INHIBITORS OF CORONAVIRUS PROTEASE

adminAugust 25, 20203 min read

For Immediate Release, August 25, 2020. Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), apharmaceutical company focused on the research, development and commercialization ofoncology and antiviral drugs…